Clinical trials
Therapy clinical trials
Below are recruiting therapy clinical trials, each written for real people, not researchers. We’re tracking 7,173 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05349552Recruiting
Radiation for lung or chest cancers in specific locations
This trial studies how safe and effective a type of focused radiation called SBRT is for cancer tumors in certain chest locations. It’s meant for people whose tumor is small (up to 5 cm) and who don’t have widespread, uncontrolled spread.
Beijing, Beijing MunicipalityAges 18–80 - NCT05173272RecruitingPhase 3
Immunotherapy plus chemo, then radiation, for advanced cervical cancer
This study tests whether adding immunotherapy to chemotherapy, then giving chemotherapy together with radiation, works better for advanced cervical cancer. It aims to improve cancer control and help people live longer, without major safety issues.
Chengdu, SichuanAges 18 years+ - NCT05553873Recruiting
Study links inflammation levels to outcomes in MPN patients
This study looks at inflammation-related lab markers in people with “Ph-negative” myeloproliferative neoplasms (like PV, ET, or PMF) to see how they relate to outcomes and response to treatment. It’s observational, meaning it gathers information from medical records without testing a new treatment.
BariAges 18–99 - NCT07867639Recruiting
Breathing muscle training after burn injuries
This study tests a breathing exercise program to help people with burn injuries on the face and chest recover their breathing strength. If you have had a moderate to severe burn, this training may help you breathe better.
GizaAges 20–50 - NCT07865403Recruiting
Online psychological support for fibromyalgia
This trial tests an online program that combines psychological support with physical rehabilitation to help manage fibromyalgia symptoms. It aims to improve well-being and daily functioning from home.
Rome, RomeAges 18–70 - NCT07867808Enrolling by invitation
Magnetic therapy versus water therapy for chronic pelvic pain
This study compares two non-drug treatments—pulsed electromagnetic therapy and hydrotherapy (warm water therapy)—to see which one better relieves long-term pelvic pain in men. If you have chronic pelvic pain from non-bacterial prostatitis, this trial could help you find a new way to manage your symptoms.
AmmanAges 42–52 - NCT06187090Recruiting
Supplement therapy for adults with autism
This trial tests whether a specific supplement can help adults with Level 1 autism. It is open only to Italian-speaking participants aged 18–35 who do not have other major mental health or brain conditions.
Udine, UDAges 18–35 - NCT06185569Recruiting
French study on outcomes in HR+/HER2- early breast cancer patients with Oncotype DX
This study looks at how well treatments work for people with early-stage, hormone receptor-positive, HER2-negative breast cancer when the Oncotype DX test helps guide therapy. It aims to understand real-world outcomes in French patients.
BesançonAges 18 years+ - NCT06185920Recruiting
A study of phage therapy for severe infections
This study looks at how well phage therapy (a virus that kills bacteria) works for severe infections. It's for people who received this treatment at a specific hospital in France.
LyonAges Any age - NCT06190639RecruitingPhase 2
Sintilimab after surgery for node-positive esophageal cancer
This trial tests whether giving the immunotherapy drug Sintilimab after surgery can help prevent esophageal cancer from coming back. It is for people whose cancer had spread to lymph nodes and who have already had their tumor removed.
Hangzhou, ZhejiangAges 18 years+ - NCT06196255RecruitingPhase 1/Phase 2
CAR-T cell therapy for resistant or relapsed multiple myeloma
This trial tests a new CAR-T cell therapy that targets FcRL5 on myeloma cells. It's for people whose myeloma has come back or stopped responding to other treatments, including stem cell transplant.
Xuzhou, JiangsuAges 18–70 - NCT07871110RecruitingPhase 2
New pill combined with hormone therapy for advanced prostate cancer
This study tests a new pill (TT00420) taken with standard hormone therapy for prostate cancer that has spread and is no longer responding to initial hormone treatment. The goal is to see if the combination can help slow the cancer's growth and is safe.
Fuzhou, FujianAges 18 years+ - NCT06204744Recruiting
Home arm and hand exercises after stroke
This trial tests a home-based exercise program for people who have weakness in one arm or hand after their first stroke. It aims to help improve movement and function without needing to go to a clinic.
Chiayi CityAges 20 years+ - NCT07874100Recruiting
Personalized treatment for acute myeloid leukemia
This study looks for markers in your blood to help doctors choose the most effective treatment, especially a drug called venetoclax. By understanding your leukemia at a very detailed level, they hope to improve outcomes for you and others.
MilanAges 18 years+ - NCT06450730Recruiting
Smartphone support program for young people with type 1 diabetes
This study tests a smartphone app plus talk therapy to help young people with type 1 diabetes feel better emotionally. You would use the app and have virtual sessions to learn ways to cope with diabetes.
Córdoba, CórdobaAges 6–18 - NCT07857499Recruiting
Nerve stimulation plus exercise for lipedema leg pain
This trial tests whether a gentle nerve stimulation device worn on the ear, combined with exercise, can reduce leg pain and swelling in women with lipedema. It aims to improve how well standard rehabilitation works for this condition.
Istanbul, EyupsultanAges 18–65 - NCT06123494RecruitingPhase 3
A trial of SHR-A1811 for HER2-positive gastric cancer
This trial tests a new drug, SHR-A1811, for people with HER2-positive stomach or gastroesophageal junction cancer that has worsened after initial treatment. It aims to see if this drug can help when standard anti-HER2 therapy stops working.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06209294RecruitingPhase 2
New drug combo before fertility-sparing surgery for cervical cancer
This trial tests a combination of immunotherapy (AK104) and standard chemotherapy before surgery for a certain type of early-stage cervical cancer. The goal is to see if this approach can help shrink the tumor enough to allow fertility-preserving surgery, so you may be able to keep your uterus.
Shanghai, Shanghai MunicipalityAges 18–45 - NCT06058078RecruitingPhase 2
Cell therapy for active lupus nephritis
This trial tests a new cell therapy (RY_SW01) for people with active lupus nephritis (kidney inflammation caused by lupus) who haven't responded well to standard treatments. It aims to see if the therapy can help control the disease.
Nanjing, JiangsuAges 18–65 - NCT06135909Recruiting
CHASE registry for pulmonary hypertension patients on treatment
This study is a registry that collects information on people with pulmonary hypertension who are using or starting targeted medications. The goal is to understand how these treatments work in real-world settings and improve care for patients like you.
BeijingAges 18–85 - NCT06058091RecruitingPhase 1/Phase 2
Cell injection therapy for systemic sclerosis
This trial tests a new cell injection treatment (RY_SW01) for people with systemic sclerosis (a condition causing skin thickening and organ issues). It aims to see if the therapy can improve skin hardening and overall symptoms.
Nanjing, JiangsuAges 18–65 - NCT06216782Recruiting
Neoadjuvant therapy for lung cancer: a real-world study
This study observes patients with lung cancer who receive neoadjuvant therapy (treatment before surgery) to understand how well it works in everyday medical practice.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06215625Recruiting
Smart arm rehab for stroke and spinal cord injury
This study tests a smart home-based upper limb rehabilitation program for people with stroke or spinal cord injury. It uses technology to help improve arm and hand movement.
TainanAges 20–79 - NCT06590857RecruitingPhase 1/Phase 2
Study of targeted radiation for advanced breast cancer
This trial tests a new type of radiation therapy that targets a specific protein on some breast cancer cells. It may help people whose cancer has stopped responding to other treatments.
Phoenix, ArizonaAges Any age
Hear when a new Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for therapy?
- Yes. Clin2 currently lists 7,173 recruiting therapy studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a therapy trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a therapy trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.